View Older Stories View More Recent Stories

Mar 5, 2026 05:05PM Form 497K WILLIAM BLAIR FUNDS
Mar 5, 2026 05:04PM Form 485BPOS WILLIAM BLAIR FUNDS
Mar 5, 2026 04:27PM William Blair Reiterates Outperform Rating on BJ's Wholesale (BJ), but "we expect BJ’s will deliver first-quarter comps below 2%"
Mar 5, 2026 02:08PM William Blair Reiterates Market Perform Rating on WillScot Holdings Corp (WSC): "we expect project activity to remain depressed"
Mar 5, 2026 01:02PM William Blair Reiterates Market Perform Rating on Zillow (Z) following stock buyback announcements
Mar 5, 2026 12:38PM Analysis-Down but not out: Emerging markets could endure Middle East shocks, investors say
Mar 5, 2026 11:55AM William Blair Reiterates Outperform Rating on Sight Sciences Inc. (SGHT) following earnings call
Mar 5, 2026 11:39AM William Blair Reiterates Outperform Rating on Monolithic Power Systems (MPWR)
Mar 5, 2026 11:37AM William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)
Mar 5, 2026 11:35AM William Blair Reiterates Outperform Rating on USA Rare Earth Inc (USAR): "We believe shares could trade at a 10x multiple"
Mar 5, 2026 11:31AM William Blair Reiterates Market Perform Rating on Altimmune (ALT)
Mar 5, 2026 11:28AM William Blair Reiterates Outperform Rating on Manhattan Associates, Inc. (MANH) following stock buyback announcement
Mar 5, 2026 09:34AM William Blair Reiterates Outperform Rating on Stryker (SYK): "upside potential from international and M&A"
Mar 5, 2026 08:40AM William Blair Reiterates Outperform Rating on Lennox International (LII): "believe the HVAC market is finding a bottom"
Mar 5, 2026 08:05AM William Blair Reiterates Outperform Rating on Riley Exploration Permian Inc. (REPX) following earnings
Mar 4, 2026 08:00PM Medline prices secondary offering at $41 per share
Mar 4, 2026 08:00PM Medline Inc. announces pricing of secondary offering of class A common stock
Mar 4, 2026 02:53PM William Blair Reiterates Outperform Rating on Real Brokerage Inc. (REAX)
Mar 4, 2026 11:26AM William Blair Reiterates Outperform Rating on Latham Group Inc. (SWIM)
Mar 4, 2026 08:39AM William Blair Reiterates Market Perform Rating on Abercrombie & Fitch (ANF): "we see shares holding wide trading range"
Mar 4, 2026 08:31AM Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
Mar 4, 2026 08:04AM William Blair Reiterates Outperform Rating on MP Materials (MP): "Key player" amid strained U.S.-China relations
Mar 3, 2026 05:53PM William Blair Reiterates Outperform Rating on Accenture plc (ACN) following acquisition announcement
Mar 3, 2026 05:25PM William Blair Reiterates Outperform Rating on Korn/Ferry (KFY): Q3 "should be fine"
Mar 3, 2026 04:04PM William Blair Reiterates Outperform Rating on Carnival Corporation (CCL) "given the muted valuation"
Mar 3, 2026 03:43PM William Blair Reiterates Outperform Rating on Booz Allen Hamilton (BAH): "Regaining its footing"
Mar 3, 2026 03:15PM William Blair Reiterates Outperform Rating on Harrow Health (HROW): "We believe the long-term growth outlook is attractive"
Mar 3, 2026 11:52AM CoStar Group stock rises after CEO buys $2.5M in shares
Mar 3, 2026 11:39AM William Blair Reiterates Outperform Rating on CoStar Group (CSGP) amid CEO buy
Mar 3, 2026 10:09AM William Blair Reiterates Outperform Rating on Aehr Test Systems (AEHR); "We find this order incremental to our thesis"
Mar 3, 2026 10:03AM William Blair Reiterates Outperform Rating on Ingram Micro (INGM); "Xvantage platform is a key differentiator"
Mar 3, 2026 09:37AM CrossCountry Consulting Acquires CNM, Expanding West Coast Presence
Mar 3, 2026 09:04AM William Blair Reiterates Outperform Rating on Dave Inc (DAVE); "We think investors should add to positions"
Mar 3, 2026 09:00AM Breezeway Announces Strategic Growth Investment from Resurgens to Accelerate AI Innovation and Global Expansion
Mar 3, 2026 08:09AM William Blair Reiterates Outperform Rating on On Holding AG (ONON); "near-term systematic pressures present buying opportunity"
Mar 3, 2026 08:06AM William Blair Reiterates Outperform Rating on 908 Devices Inc. (MASS)
Mar 3, 2026 05:38AM William Blair Starts Once Upon a Farm (OFRM) at Outperform
Mar 3, 2026 05:17AM Sportswear brand On sees possible boost from lower US tariff rate
Mar 2, 2026 04:40PM William Blair Reiterates Outperform Rating on HEICO (HEI)
Mar 2, 2026 04:31PM Ares closes $850 million continuation vehicle for Convergint
Mar 2, 2026 04:30PM Ares Closes $850 Million Single-Asset Continuation Vehicle for Convergint Led by Leonard Green & Partners
Mar 2, 2026 03:17PM William Blair Reiterates Outperform Rating on Zoetis Inc. (ZTS) after announcing accusation of Neogen's genomics business
Mar 2, 2026 03:15PM William Blair Reiterates Market Perform Rating on Neogen (NEOG) amid genomics business sale
Mar 2, 2026 03:06PM William Blair Reiterates Outperform Rating on Silence Therapeutics (SLN)
Mar 2, 2026 12:57PM William Blair Reiterates Outperform Rating on Agilysys Inc (AGYS); "very positive view on the outlook for Agilysys"
Mar 2, 2026 12:05PM William Blair Upgrades Intellia Therapeutics (NTLA) to Outperform
Mar 2, 2026 10:24AM William Blair Reiterates Outperform Rating on Klaviyo Inc (KVYO) following stock buyback announcement
Mar 2, 2026 10:19AM William Blair Reiterates Outperform Rating on Ocular Therapeutix (OCUL) following study results
Mar 2, 2026 09:33AM William Blair on AAON Inc (AAON): 'Sales and Backlog Very Healthy, but Gross Margins Miss'
Mar 2, 2026 07:35AM Defense stocks surge on Middle East conflict escalation
View More Recent Stories View Older Stories